The Treat-to-Target Trial
Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
Article Information
vol. 26 no. 11 3080-3086
PubMed
Published By
Print ISSN
Online ISSN
History
- July 23, 2003
- February 18, 2003
- Published in print October 24, 2003.
Copyright & Usage
DIABETES CARE
Author Information
- Matthew C. Riddle, MD1,
- Julio Rosenstock, MD2,
- John Gerich, MD3 and
- on behalf of the Insulin Glargine 4002 Study Investigators*
- 1Oregon Health and Science University, Portland, Oregon
- 2Dallas Diabetes and Endocrine Center, Dallas, Texas
- 3University of Rochester Medical Center, Rochester, New York
- Address correspondence and reprint requests to Matthew C. Riddle, MD, Oregon Health and Science University, Section of Diabetes L-345, 3181 S.W. Sam Jackson, Portland, OR 97201. E-mail: riddlem{at}ohsu.edu